Successful Treatment of Adult Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis With Etoposide Guided by Plasma Epstein-Barr Virus DNA Monitoring: A Case Report [0.03%]
依托泊苷联合抗病毒及血浆置换治疗成人EB病毒相关噬血细胞性淋巴组织细胞增多症1例
Kuniaki Maehara,Masuho Saburi,Katsuya Kawano et al.
Kuniaki Maehara et al.
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome. Epstein-Barr virus (EBV)-associated HLH is a major subtype of secondary HLH, requiring prompt diagnosis and treatment. However, treatment is particul...
Polatuzumab Vedotin Enhances Intratumoral T-Cell Infiltration and Demonstrates Combinatorial Efficacy With Anti-CD20/CD3 Bispecific Antibody in a Syngeneic B-Cell Malignancy Mouse Model [0.03%]
Polatuzumab Vedotin增强肿瘤浸润T细胞并联合抗CD20/CD3双特异性抗体在同基因B细胞恶性肿瘤小鼠模型中显示出协同疗效
Mayu Tomita,Sei Shu,Natsumi Kawasaki et al.
Mayu Tomita et al.
Introduction: Polatuzumab vedotin (Pola) is an anti-CD79b antibody-drug conjugate. Clinical evidence supports the combination efficacy of Pola with mosunetuzumab or glofitamab, both anti-CD20/CD3 bispecific antibodies (an...
Immune Effector Cell-Associated Hematotoxicity With Secondary Myelofibrosis Following Idecabtagene-Vicleucel for Multiple Myeloma, Comprehensively Treated With Autologous Hematopoietic Stem Cell Boosting [0.03%]
伊代卡巴泰吉恩-维克留塞治疗多发性骨髓瘤后继发性骨髓纤维症相关的免疫效应细胞相关血液毒性,自体造血干细胞助推全面治疗
Keishi Ogura,Takahiro Fujino,Takahisa Nakamura et al.
Keishi Ogura et al.
Pancytopenia accompanied by chimeric antigen receptor T cell (CAR-T) therapy is termed immune effector cell-associated hematopoietic toxicity (ICAHT), which is often sustained and refractory to supportive care. We report a case of a 52-year...
Effectiveness and Safety of Prophylactic Low-Dose Emicizumab in Young Children With Hemophilia A: A Multicenter Retrospective Study [0.03%]
预防性低剂量艾美赛珠单抗在甲型血友病年轻患儿中疗效及安全性的多中心回顾研究
Guichi Zhou,Liya He,Chunyan Wang et al.
Guichi Zhou et al.
Background: Real-world data on low-dose emicizumab in young children with hemophilia A are limited. Methods: This multicenter retrospec...
Targeting CD162 for Life-Threatening Cutaneous Chronic Graft-Versus-Host Disease: A Case Report [0.03%]
针对CD162的特异性治疗用于危及生命的皮肤慢性移植物抗宿主病:一例报告
Alicia Lieberman,Ross McCauley,Maureen Ross et al.
Alicia Lieberman et al.
Steroid-refractory chronic cutaneous graft-versus-host disease (GVHD) causes substantial morbidity, prolonged hospitalization, and non-relapse mortality after allogeneic hematopoietic cell transplantation. We report a young adult with multi...
Identifying Educational and Resource Needs of General Internal Medicine Physicians in Sickle Cell Disease Management [0.03%]
识别一般内科医师在镰状细胞病管理中的教育和资源需求
Anas Samman,Victoria David,Roy Khalife et al.
Anas Samman et al.
Introduction: Sickle cell disease involves acute and chronic complications requiring timely recognition and multidisciplinary care. General internal medicine (GIM) physicians often manage affected adults with limited expo...
Utility of Flow Cytometry for Prognostic Prediction in Adult T-Cell Leukemia/Lymphoma [0.03%]
流式细胞术在成人T细胞白血病/淋巴瘤预后预测中的应用价值
Shigeo Fuji,Masahito Tokunaga,Lucy Cook et al.
Shigeo Fuji et al.
Introduction: Adult T-cell leukemia/lymphoma (ATL) exhibits marked clinical heterogeneity; however, current classification primarily rely on morphology and laboratory findings and require further advancement. This study a...
MRI Predictors of Outcome in Primary Central Nervous System Lymphoma Patients Before and After Autologous Stem Cell Transplant [0.03%]
自身干细胞移植前后原发中枢神经系统淋巴瘤患者磁共振影像预后因素分析
Dewen Meng,Hamza Alshuft,Christopher P Fox et al.
Dewen Meng et al.
Introduction: Primary CNS lymphoma (PCNSL) is treated with intensive chemotherapy and autologous stem cell transplant (HDT-ASCT), yet up to one-third of patients relapse. Standard MRI response criteria may not reliably di...
Sequential Use of Recombinant Porcine Factor VIII and Early Emicizumab in Acquired Hemophilia A: A Case Series [0.03%]
重组猪源性VIII因子联合emicizumab治疗获得性血友病A的序贯疗法:病例系列报告
Yusuke Yamada,Takashi Onaka,Kazunori Imada
Yusuke Yamada
Background: Acquired hemophilia A (AHA) is a rare autoimmune bleeding disorder requiring prompt hemostatic control and sustained prevention of rebleeding. Recombinant porcine factor VIII (rpFVIII, susoctocog alfa) control...
Sinusoidal Obstruction Syndrome With Inotuzumab Ozogamicin Combined With Ponatinib for Philadelphia-Chromosome-Positive Lymphoblastic Malignancies [0.03%]
与帕博珠单抗合用治疗费城染色体阳性淋巴母细胞恶性肿瘤所致的窦性梗阻综合征
Emi Yokoyama,Satoshi Ota,Yasuo Sakurai et al.
Emi Yokoyama et al.
Introduction: Sinusoidal obstruction syndrome, also known as veno-occlusive disease (SOS/VOD), can occur after exposure to inotuzumab ozogamicin (InO), a calicheamicin-based antibody-drug conjugate. ...